Skip to Content

People With Movement Disorders May Become Immune to Botox Therapy

FRIDAY, Dec. 28, 2018 -- Some people who receive botulinum toxin injections for disorders that cause muscle tightness and contractions develop resistance to the treatment, researchers say.

The new study included nearly 600 patients with dystonia or spasticity who had been receiving botulinum toxin type A (commonly known as "Botox") for about three to five years.

The researchers found that about 15 percent of the patients developed an immune response that made the treatment less effective or ineffective.

"People may be able to lessen their chances of developing this response by making sure the dose of the drug in each injection is as low as possible, the time between injections is not shortened and booster injections are avoided," study author Dr. Philipp Albrecht said in a news release from the American Academy of Neurology.

Albrecht is a member of the medical faculty at Heinrich Heine University in Dusseldorf, Germany.

The study findings were published online recently in the journal Neurology.

According to the American Association of Neurological Surgeons (AANS), spasticity is a condition in which certain muscles are continuously contracted, which can interfere with normal movement and speech. Spasticity is usually caused by damage to the portion of the brain or spinal cord that controls voluntary movement.

Dystonia is a complex neurological disorder characterized by involuntary muscle contractions. As many as 250,000 people in the United States have dystonia, making it the third most common movement disorder after essential tremor and Parkinson's disease, the AANS says.

© 2020 HealthDay. All rights reserved.

Posted: December 2018

Read this next

Pregnancy May Delay MS

FRIDAY, Sept. 18, 2020 -- Pregnancy can delay the onset of multiple sclerosis (MS) by more than three years, researchers report. The international study found those who'd been...

Many MS Patients Struggle With Finances, Forgo Treatments

TUESDAY, Sept. 15, 2020 -- More than three-quarters of Americans with multiple sclerosis (MS) experience financial difficulties that often prevent them from getting treatment, new...

Ofatumumab May Beat Older Drug at Preventing MS Relapse

WEDNESDAY, Aug. 5, 2020 -- A new injection drug can prevent multiple sclerosis flare-ups better than an existing medication, a clinical trial has found. The drug, called...